Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI
- Tae Hyun Yang
- , Han Young Jin
- , Kyu Nam Choi
- , Ungjeong Do
- , Hyung Jun Kim
- , Sang Ryul Chung
- , Jeong Sook Seo
- , Jae Sik Jang
- , Dae Kyeong Kim
- , Dong Soo Kim
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations